TransMedics Group (NASDAQ:TMDX – Get Free Report) and Vivani Medical (NASDAQ:VANI – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.
Profitability
This table compares TransMedics Group and Vivani Medical’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
TransMedics Group | -3.43% | 7.95% | 1.61% |
Vivani Medical | N/A | -93.91% | -47.76% |
Institutional and Insider Ownership
99.7% of TransMedics Group shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 7.0% of TransMedics Group shares are owned by company insiders. Comparatively, 55.6% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Analyst Recommendations
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
TransMedics Group | 0 | 1 | 9 | 0 | 2.90 |
Vivani Medical | 0 | 0 | 0 | 0 | N/A |
TransMedics Group presently has a consensus target price of $133.88, indicating a potential downside of 5.85%. Given TransMedics Group’s higher probable upside, equities analysts clearly believe TransMedics Group is more favorable than Vivani Medical.
Risk & Volatility
TransMedics Group has a beta of 1.98, meaning that its share price is 98% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.23, meaning that its share price is 223% more volatile than the S&P 500.
Valuation & Earnings
This table compares TransMedics Group and Vivani Medical’s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
TransMedics Group | $241.62 million | 19.38 | -$25.03 million | ($0.34) | -418.21 |
Vivani Medical | N/A | N/A | -$25.65 million | ($0.50) | -2.68 |
TransMedics Group has higher revenue and earnings than Vivani Medical. TransMedics Group is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.
Summary
TransMedics Group beats Vivani Medical on 8 of the 12 factors compared between the two stocks.
About TransMedics Group
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
About Vivani Medical
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Receive News & Ratings for TransMedics Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransMedics Group and related companies with MarketBeat.com's FREE daily email newsletter.